Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches
Neural transplantation is developing into a therapeutic alternative in Parkinson's disease. A major limiting factor is that only 3–20% of grafted dopamine neurons survive the procedure. Recent advances regarding how and when the neurons die indicate that events preceding actual tissue implantat...
Main Authors: | Patrik Brundin, Jenny Karlsson, Mia Emgård, Gabriele S. Kaminski Schierle, Oskar Hansson, Åsa Petersén, Roger F. Castilho |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2000-03-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/096368970000900205 |
Similar Items
-
Grafting of Nigral Tissue Hibernated with Tirilazad Mesylate and Glial Cell Line-Derived Neurotrophic Factor
by: Åsa Petersén, et al.
Published: (2000-09-01) -
Pretreatment with MK-801 or the Lazaroid U-83836E does not Enhance Striatal Graft Survival
by: Ulrika Mundt-Petersen, et al.
Published: (2000-01-01) -
Addition of Lateral Ganglionic Eminence to Rat Mesencephalic Grafts Affects Fiber Outgrowth but Does not Enhance Function
by: Mia Emgard-Mattson, et al.
Published: (1997-05-01) -
Effects of Antioxidant Pretreatment on the Survival of Embryonic Dopaminergic Neurons In Vitro and following Grafting in an Animal Model of Parkinson's Disease
by: R. M. Love, et al.
Published: (2002-10-01) -
Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.
by: Elodie Angot, et al.
Published: (2012-01-01)